Clifford Bechtold
Compliance Officer bei BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Profil
Herr Clifford Bechtold ist ein Chief Operating Officer bei Biohaven Pharmaceutical Holding Co. Ltd. Herr Bechtold war zuvor als Vice President-Strategic Operations bei Adnexus und als Staff Director bei Bristol Myers Squibb Co. beschäftigt. Er erhielt seinen Bachelor-Abschluss von der South Dakota State University und einen Abschluss von der Creighton University School of Medicine.
Aktive Positionen von Clifford Bechtold
Unternehmen | Position | Beginn |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Compliance Officer | - |
BIOHAVEN LTD. | Compliance Officer | - |
Ehemalige bekannte Positionen von Clifford Bechtold
Unternehmen | Position | Ende |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.11.2013 |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01.10.2011 |
Ausbildung von Clifford Bechtold
South Dakota State University | Undergraduate Degree |
The Creighton University School of Medicine | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
BIOHAVEN LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Health Technology |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |